We demonstrated that EAEP protected against scopolamine-induced memory impairment, and that the neuroprotective effects of EAEP may regulate the cholinergic nervous system, the antioxidant defense system, and the BDNF/TrkB/Akt-signaling pathway. The gene discussed is AKT1; the disease is memory impairment.